Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Decreased Expression of Anti-DNMT1 Tumor-Suppressor microRNAs in Azacitidine (AZA)-Resistant Cells Independently Predicts Survival in Patients Treated with AZA for Higher Risk Myelodysplastic Syndrome (HRMDS) and Oligoblastic Acute Myeloid Leukemia (AML)

Francoise Solly, MD, Catherine Koering, PhD, Aminetou mint Mohamed, PhD, Delphine Maucort-Boulch, MD, Guillaume Robert, PhD, Patrick Auberger, PhD, Pascale Flandrin-Gresta, MDPhD, Lionel Adès, MD PhD, Pierre Fenaux, MD PhD, Olivier Kosmider, MD PhD, Emmanuelle Tavernier-Tardy, MDPhD, Jérôme Cornillon, MD, Denis Guyotat, MDPhD, Lydia Campos, MD PhD, Franck Mortreux, PhD, Eric Wattel, MDPhD

Blood (2015) 126 (23): 2840.

https://doi.org/10.1182/blood.V126.23.2840.2840

Published: 2015

Journal Articles

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Eve Poret, Fanny Angelot Delettre, Sabeha Biichle, Anne Roogy, Louis Benazet, Maider Pagadoy, Chrystelle Vidal, Franck Leroux, Véronique Harrivel, Christophe Ferrand, PhD, Veronique Salaun, Zehaira Benseddik, Julien Guy, Marie Christine Jacob, Christophe Roumier, Jean Feuillard, Liliana Vila, Lucile Baseggio, Adriana Plesa, Christine Arnoulet, B Benet, Bernard Drenou, MD, Veronique Latger Cannard, Marie-Christine Bene, MD, Michel Ticchioni, Daniel Lusina, Valerie Bardet, Magalie LE Garff Tavernier, Elizabeth Macintyre, MD PhD, Vahid Asnafi, MDPhD, Maria Elena Noguera, Sabrina Bouyer, Carine Lecoq Lafon, Mikael Roussel, MD PhD, Fabrice Jardin, Francoise Solly, MD, Lydia Campos, MD PhD, Anne Galoisy, Anne Arnaud, Sylvie Daliphard, Franck Genevieve, MD PhD, Romaric Lacroix, Françoise Schillinger, Estelle Seilles, Delphine Binda, Eric Deconinck, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2015) 126 (23): 3812.

https://doi.org/10.1182/blood.V126.23.3812.3812

Published: 2015

Journal Articles

Skipping of ATP-Binding Cassette Transporter A3 Exon 19 in AML Cells Is an Independent Prognostic Factor in Patients with Normal Cytogenetics

Blood (2014) 124 (21): 2324.

https://doi.org/10.1182/blood.V124.21.2324.2324

Published: 2014

Journal Articles

Minimal Residual Disease (MRD) By 8-Color Flow Cytometry (Flow-MRD) and IGH Clonospecific Quantitative PCR (ASO RQPCR) Reached Similar Performances for Evaluation of CLL Treatment in a Phase II Clinical Trial: Cross Validation of the Methods

Remi Letestu, MD PhD, Guillaume Cartron, MD, Stephane Lepretre, MD, Magali Le Garff-Tavernier, PharmD, PhD, Francoise Solly, MD, Lydia Campos, MD PhD, Michel Ticchioni, MD PhD, Claire Quiney, Abdelmalek Dahmani, Marouane Boubaya, Vincent Levy, MD PhD, Florence Cymbalista, MD, Marie-Helene Delfau-Larue, MD PhD

Blood (2014) 124 (21): 3307.

https://doi.org/10.1182/blood.V124.21.3307.3307

Published: 2014

Journal Articles

TET2 Exon 2 Skipping Confers Sensitivity to AraC and Is an Independent Favorable Prognostic Factor in AML Patients Treated with Intensive Chemotherapy

Blood (2014) 124 (21): 68.

https://doi.org/10.1182/blood.V124.21.68.68

Published: 2014

Journal Articles

Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry

Blood (2013) 122 (21): 2613.

https://doi.org/10.1182/blood.V122.21.2613.2613

Published: 2013

Journal Articles

Interest of Early Determination of Bone Marrow MRD by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: The Experience of the CLL2007FMP, An Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine Cyclophosphamide (FC) and Rituximab (FCR) Versus FC and MabCampath (FCCam) in Previously Untreated B-Chronic Lymphocytic Leukemia Patients

Remi Letestu, MD, Stéphane Leprêtre, MD, Christine Arnoulet, Pharm. D., Lucile Baseggio, Lydia Campos, MD, PhD, Bernard Chatelain, Bernard Drenou, MD, PhD, Marie-Christine Jacob, Eric Legac, Magali Le Garff-Tavernier, Nelly Robillard, Michel Ticchioni, Roselyne Delepine, Vincent Levy, MD, Sandrine Katsahian, Veronique Leblond, Florence Cymbalista, Pr, Pierre Feugier, MD, PhD

Blood (2011) 118 (21): 1797.

https://doi.org/10.1182/blood.V118.21.1797.1797

Published: 2011

Journal Articles

CD133 + Acute Myeloid Leukemia (AML) Cells Exhibit Higher Clonogenic Capacity and Higher Levels of pAKT and Bcl-2 Proteins Than Their Negative Counterpart

Francoise Solly, Lauren Rigollet, Pascale Flandrin-Gresta, Karine Augeul-Meunier, Emmanuelle Tavernier-Tardy, Nathalie Nadal, Denis Guyotat, Lydia Campos, MD, PhD

Blood (2010) 116 (21): 1721.

https://doi.org/10.1182/blood.V116.21.1721.1721

Published: 2010

Journal Articles

High Pro-Apoptotic Effects of 17-Allylamino-17-Demethoxy Geldanamycin (17-AAG) In Philadelphia Acute Lymphoblastic Leukemia (Ph+ ALL)

Emmanuelle Tavernier-Tardy, Pascale Flandrin, Francoise Solly, Jérôme Cornillon, Karine Augeul-Meunier, Jean-Louis Stephan, Denis Guyotat, Lydia Campos, MD, PhD

Blood (2010) 116 (21): 3226.

https://doi.org/10.1182/blood.V116.21.3226.3226

Published: 2010

Journal Articles

High Levels of Heat Shock Proteins 90 and 27 in CD34-Positive Cells from Myelodysplastic Syndromes (MDS) Are Associated with Higher Expression and Activation of Focal Adhesion Kinase (FAK) and with Disease Progression.

Françoise Solly, Pascale Flandrin-Gresta, Carmen Aanei, Jérôme Cornillon, Emmanuelle Tavernier, Denis Guyotat, MD, PhD, Lydia Campos, MD, PhD

Blood (2009) 114 (22): 289.

https://doi.org/10.1182/blood.V114.22.289.289

Published: 2009

Journal Articles

Apoptosis-Independent Activation of Caspase-3 in CD34–Positive (CD34+) Mobilized Cells.

Karine Augeul-Meunier, Carine Crampé, Philippe Farce, Christiane Mounier, Denis Guyotat, Lydia Campos, MD, PhD

Blood (2008) 112 (11): 2305.

https://doi.org/10.1182/blood.V112.11.2305.2305

Published: 2008

Journal Articles

Prognostic Value of CXCR4, Adhesion Molecules and Heat Shock Proteins (HSP) in Acute Myelogenous Leukemia.

Emmanuelle Tavernier, MD, Amelie Duval, Jerome Cornillon, MD, Pascale Flandrin, MD, Denis Guyotat, MD, Lydia Campos, MD, PhD

Blood (2007) 110 (11): 2848.

https://doi.org/10.1182/blood.V110.11.2848.2848

Published: 2007

Journal Articles

Activation of Multiple Signal Transduction Pathways as a Prognostic Marker in Acute Myelogenous Leukemia.

Pascale Flandrin-Gresta, MD, Lydia Campos, MD, PhD, Emmanuelle Tavernier-Tardy, MD, Amelie Duval, MD, Nathalie Nadal, MD, Denis Guyotat, MD, PhD

Blood (2007) 110 (11): 2395.

https://doi.org/10.1182/blood.V110.11.2395.2395

Published: 2007

Journal Articles

Novel Leukemia Associated Immunophenotype (LAIP) Absent from Normal and Regenerating Bone Marrow Identified by Multiparameter 6-Color Flow Cytometry.

Denis Guyotat, MD, Daniela Olaru, MD, Pascale Flandrin, MD, Nathalie Nadal, MD, Lydia Campos, MD PhD

Blood (2006) 108 (11): 2362.

https://doi.org/10.1182/blood.V108.11.2362.2362

Published: 2006

Journal Articles

Evaluation of Focal Adhesion Kinase Gene Expression in Leukemia and Cancer Cell Lines Using Combined Molecular Cytogenetic Investigations and Quantitative Real Time RT-PCR.

Lydia Campos, MD, PhD, Andrei Tchirkov, MD, Jerome Cornillon, MD, Mirella Mihaescu, MD, Michel Giollant, MD, Simone Piselli, Philippe Vago, MD, PhD, Michele Cottier, MD

Blood (2004) 104 (11): 4282.

https://doi.org/10.1182/blood.V104.11.4282.4282

Published: 2004

Journal Articles

Hsp90 Inhibitors Induce Apoptosis in Human Leukemia Cells.

Lydia Campos, MD, PhD, Pascale Flandrin, PharmD, Daniela Olaru, MD, Denis Guyotat, MD

Blood (2004) 104 (11): 93.

https://doi.org/10.1182/blood.V104.11.93.93

Published: 2004

NARROW

Decreased Expression of Anti-DNMT1 Tumor-Suppressor microRNAs in Azacitidine (AZA)-Resistant Cells Independently Predicts Survival in Patients Treated with AZA for Higher Risk Myelodysplastic Syndrome (HRMDS) and Oligoblastic Acute Myeloid Leukemia (AML)

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Skipping of ATP-Binding Cassette Transporter A3 Exon 19 in AML Cells Is an Independent Prognostic Factor in Patients with Normal Cytogenetics

Minimal Residual Disease (MRD) By 8-Color Flow Cytometry (Flow-MRD) and IGH Clonospecific Quantitative PCR (ASO RQPCR) Reached Similar Performances for Evaluation of CLL Treatment in a Phase II Clinical Trial: Cross Validation of the Methods

TET2 Exon 2 Skipping Confers Sensitivity to AraC and Is an Independent Favorable Prognostic Factor in AML Patients Treated with Intensive Chemotherapy

Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry

CD133 + Acute Myeloid Leukemia (AML) Cells Exhibit Higher Clonogenic Capacity and Higher Levels of pAKT and Bcl-2 Proteins Than Their Negative Counterpart

High Pro-Apoptotic Effects of 17-Allylamino-17-Demethoxy Geldanamycin (17-AAG) In Philadelphia Acute Lymphoblastic Leukemia (Ph+ ALL)

High Levels of Heat Shock Proteins 90 and 27 in CD34-Positive Cells from Myelodysplastic Syndromes (MDS) Are Associated with Higher Expression and Activation of Focal Adhesion Kinase (FAK) and with Disease Progression.

Apoptosis-Independent Activation of Caspase-3 in CD34–Positive (CD34+) Mobilized Cells.

Prognostic Value of CXCR4, Adhesion Molecules and Heat Shock Proteins (HSP) in Acute Myelogenous Leukemia.

Activation of Multiple Signal Transduction Pathways as a Prognostic Marker in Acute Myelogenous Leukemia.

Novel Leukemia Associated Immunophenotype (LAIP) Absent from Normal and Regenerating Bone Marrow Identified by Multiparameter 6-Color Flow Cytometry.

Evaluation of Focal Adhesion Kinase Gene Expression in Leukemia and Cancer Cell Lines Using Combined Molecular Cytogenetic Investigations and Quantitative Real Time RT-PCR.

Hsp90 Inhibitors Induce Apoptosis in Human Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only